Strategy, advice, and inspiration for digital marketing and social media experts

10 questions for social media customer service

August 5, 2011
Posted by: Matthew Hammer, VP- Marketing

Written by former LiveWorld employee, @BryanPerson. We regularly work with our brand clients on scenario and workflow planning for customer service and brand response on social channels, particularly Facebook. Social media is transforming customer service, and we find that many brands are still catching up and adapting to the always-on, public, and conversational nature of […]

Read more

The benefits of anonymity online

Posted by: Matthew Hammer, VP- Marketing

“I like being famous when it’s convenient for me and completely anonymous when it’s not.” – Catherine Deneuve The recent launch of Google+ has brought discussions about privacy and personae back to the table for online communities of all kinds. It’s something some social media mavens and developers seem to have failed to consider recently, […]

Read more

Jay Bryant to Pixels & Pills: Pharma brand marketing on Facebook is a manageable risk

July 18, 2011
Posted by: Matthew Hammer, VP- Marketing

Following a discussion that he led at the BDI Social Communications & Healthcare 2011 roundtables last week, our LiveWorld Sales VP, Jay Bryant, checks in with Pixels & Pills’ Sarah for a conversation about social media’s impact on the pharmaceutical industry. In the interview, Jay addresses the concern that many pharma brands raise as they participate in social […]

Read more

Adverse events only small percentage of comments on pharma Facebook Pages

July 15, 2011
Posted by: Matthew Hammer, VP- Marketing

August 15, 2011 looms as the date when disease-state and over-the-counter (OTC) pharma brands will no longer be able to prevent fans from commenting on their Facebook Pages. This also means an obligation to watch for and report all adverse events (AE) on the Page. So how much AE content should pharma brands realistically expect? To […]

Read more